<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>ALBERTSONS COMPANIES, INC.</issuerName>
    <cusip>013091103</cusip>
    <isin>US0130911037</isin>
    <meetingDate>08/07/2025</meetingDate>
    <voteDescription>Hold the annual, non-binding, advisory vote on our executive compensation program.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>151818680</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>151818680</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>COMSCORE, INC.</issuerName>
    <cusip>20564W204</cusip>
    <isin>US20564W2044</isin>
    <meetingDate>06/16/2026</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation paid to the company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>7620100</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>7620100</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
<voteOtherInfo>Represents (i) 7,620,100 shares of common stock, par value $0.001 per share ("Common Stock"), of comScore, Inc., a Delaware corporation (the "Issuer"), issuable upon conversion of 4,223,621 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.001 per share ("Series C Preferred Stock"), beneficially owned by the Reporting Person, and (ii) 3,396,479 shares of outstanding Common Stock beneficially owned by the Reporting Person.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>KEENOVA THERAPEUTICS PLC</issuerName>
    <cusip>G5890A102</cusip>
    <isin>IE000O3L0NQ3</isin>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>Advisory non-binding vote to approve the Company's executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>306929</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>306929</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>KEENOVA THERAPEUTICS PLC</issuerName>
    <cusip>G5890A102</cusip>
    <isin>IE000O3L0NQ3</isin>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>Advisory non-binding vote on frequency of future advisory non-binding votes to approve the Company's executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <sharesVoted>306929</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>1 YEAR</howVoted>
        <sharesVoted>306929</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
</proxyVoteTable>
